1. Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma
    Shun-Fa Yang et al, 2016, Sci Rep CrossRef
  2. Urban legends series: oral leukoplakia
    PG Arduino et al, 2013, Oral Dis CrossRef
  3. PIWI‐interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells
    Jyoti Roy et al, 2019, J Cell Physiol CrossRef
  4. RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC
    Mrinmoyee Majumder et al, 2016, PLoS Genet CrossRef
  5. Combinations of SERPINB5 gene polymorphisms and environmental factors are associated with oral cancer risks
    Hsiu-Ting Tsai et al, 2017, PLoS ONE CrossRef
  6. DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity
    Elaine Y Leung et al, 2017, Histopathology CrossRef
  7. A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma
    Chiao-Wen Lin et al, 2017, Oncotarget CrossRef
  8. Oral Lesions in Soft Tissues
    Sandra Beatriz Chaves Tarquinio et al, 2021 CrossRef
  9. Immunoexpression of Apoptosis and Cell-cycle Arrest Markers in Oral Lichen Planus
    Mario Pérez-Sayáns et al, 2021 CrossRef
  10. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions
    Tareq Saleh et al, 2021, Mol Pharmacol CrossRef
  11. Premalignant lesions and cellular senescence
    Eleni Georgakopoulou et al, 2022 CrossRef
  12. Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis
    Pablo Ramos-García et al, 2022, Oral Oncology CrossRef
  13. Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia
    Luís Monteiro et al, 2022, Biomolecules CrossRef
  14. Cellular senescence: the good, the bad and the unknown
    Weijun Huang et al, 2022, Nat Rev Nephrol CrossRef
  15. Senescence-associated secretory phenotype and its impact on oral immune homeostasis
    Ziqi Yue et al, 2022, Front. Immunol. CrossRef
  16. Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia
    Kushi Ranganath et al, 2022, Cancers CrossRef
  17. The vulnerable primed cancer stem cells in disguise: demystifying the role of Maspin
    Shijie Sheng et al, 2022, Cancer Metastasis Rev CrossRef
  18. Senolytic Therapy: A Potential Approach for the Elimination of Oncogene-Induced Senescent HPV-Positive Cells
    Tareq Saleh et al, 2022, IJMS CrossRef
  19. THE INFLUENCE OF TECHNOGENIC FACTORS OF THE PRODUCTION AND ENVIRONMENT ON THE PREVALENCE AND STRUCTURE OF THE PATHOLOGY OF THE DENTISTRY SYSTEM
    Zarif Yusupov et al, 2017, AB CrossRef
  20. Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer
    Tareq Saleh et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  21. An integrated RNA-proteomic landscape of drug induced senescence in a cancer cell line
    Maha Al-Roshdi et al, 2023, F1000Res CrossRef
  22. Establishment of skin cutaneous melanoma prognosis model based on vascular mimicry risk score
    Yubo Wang et al, 2024 CrossRef
  23. Computational identification of natural senotherapeutic compounds that mimic dasatinib based on gene expression data
    Franziska Meiners et al, 2024, Sci Rep CrossRef
  24. A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
    Ahmed M. Elshazly et al, 2024, Mol Pharmacol CrossRef
  25. Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue
    Ashraf I. Khasawneh et al, 2025, BMC Cancer CrossRef